*Edited by Hilal Arnouk and Bassam Abdul Rasool Hassan*

Recent advances in precision medicine and immuno-oncology have led to highly specific and efficacious cancer therapies such as monoclonal antibodies and immune checkpoint inhibitors (ICIs). This book provides an up-to-date overview of advances in the field of immuno-oncology. Chapters cover such topics as ICIs and how they mount a robust immune response against cancer cells as well as the response of ICIs to treatment predictive biomarkers and their potential immune-related adverse events (irAEs). Additionally, the book includes a comprehensive review of the powerful FDA-approved therapeutic agent doxorubicin, highlighting the molecular mechanisms behind doxorubicin's drug resistance and critical side effects.

Published in London, UK © 2021 IntechOpen © wacomka / iStock

Advances in Precision Medicine Oncology

Advances in Precision

Medicine Oncology

*Edited by Hilal Arnouk* 

*and Bassam Abdul Rasool Hassan*